Today at 10:23 am by 
Pfizer Developing RSV Vaccine to Immunize Unborn Babies While in the Womb
Date: November 8, 2022Author: Nwo Report
Posted BY: Teresa | NwoReport
Pharmaceutical giant Pfizer is developing a vaccine specifically for pregnant women that will immunize an unborn baby while still in the womb.
Pfizer claims that infants will be protected against the respiratory syncytial virus (RSV) after birth.
The Washington Post
@washingtonpost
·
Follow
Pfizer announced Tuesday that its maternal RSV vaccine, given during pregnancy, protected infants from developing severe symptoms during the first six months after birth — a critical window of vulnerability.
washingtonpost.com
Pfizer’s RSV vaccine, given during pregnancy, protects infants from severe illness
Pfizer plans to apply for approval of its RSV vaccine by year's end, in hopes a vaccine could be available before next year's respiratory-illness season.
9:57 AM · Nov 1, 2022
Jordan Schachtel @ dossier.substack.com
@JordanSchachtel
·
Follow
RSV effects 97% of children by age 2. It has a 99.9976% survival rate. There is no need for a vaccine for it. Yet Pfizer has decided that RSV can serve as a revenue stream, & they've created a maternal "vaccine" for it. They will submit it to the FDA for approval by EOY.
3:40 PM · Nov 2, 2022
Dr. Neuro
@Neurofourier
·
Follow
Huge news for the babies! Pfizer’s bivalent RSV vaccine has demonstrated amazing efficacy (81.8% against severe lower respiratory illness). This was well tolerated and with results meeting criteria, Pfizer has stopped enrollment and will plan to submit by end of 2022!
6:38 AM · Nov 1, 2022
Read the full conversation on Twitter
Thanks to: https://nworeport.me/2022/11/08/pfizer-developing-rsv-vaccine-to-immunize-unborn-babies-while-in-the-womb/
Date: November 8, 2022Author: Nwo Report
Posted BY: Teresa | NwoReport
Pharmaceutical giant Pfizer is developing a vaccine specifically for pregnant women that will immunize an unborn baby while still in the womb.
Pfizer claims that infants will be protected against the respiratory syncytial virus (RSV) after birth.
The Washington Post
@washingtonpost
·
Follow
Pfizer announced Tuesday that its maternal RSV vaccine, given during pregnancy, protected infants from developing severe symptoms during the first six months after birth — a critical window of vulnerability.
washingtonpost.com
Pfizer’s RSV vaccine, given during pregnancy, protects infants from severe illness
Pfizer plans to apply for approval of its RSV vaccine by year's end, in hopes a vaccine could be available before next year's respiratory-illness season.
9:57 AM · Nov 1, 2022
Jordan Schachtel @ dossier.substack.com
@JordanSchachtel
·
Follow
RSV effects 97% of children by age 2. It has a 99.9976% survival rate. There is no need for a vaccine for it. Yet Pfizer has decided that RSV can serve as a revenue stream, & they've created a maternal "vaccine" for it. They will submit it to the FDA for approval by EOY.
3:40 PM · Nov 2, 2022
Dr. Neuro
@Neurofourier
·
Follow
Huge news for the babies! Pfizer’s bivalent RSV vaccine has demonstrated amazing efficacy (81.8% against severe lower respiratory illness). This was well tolerated and with results meeting criteria, Pfizer has stopped enrollment and will plan to submit by end of 2022!
6:38 AM · Nov 1, 2022
Read the full conversation on Twitter
Thanks to: https://nworeport.me/2022/11/08/pfizer-developing-rsv-vaccine-to-immunize-unborn-babies-while-in-the-womb/
